Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
Revenues | 234.7 | 212.2 | 179.3 | 196.2 | 133.3 |
Revenue growth | 10.6% | 18.3% | -8.6% | 47.1% | |
Cost of goods sold | 261.4 | 228.8 | 175.3 | 113.4 | 92.1 |
Gross profit | -26.8 | -16.6 | 4.0 | 82.8 | 41.2 |
Gross margin | -11.4% | -7.8% | 2.2% | 42.2% | 30.9% |
Sales and marketing | 134.9 | 112.7 | 63.2 | 39.4 | 19.9 |
Research and development | 86.2 | 105.2 | 72.7 | 34.9 | 21.4 |
General and administrative | 203.3 | 206.0 | 100.7 | 29.5 | 19.4 |
EBIT | -457.5 | -446.1 | -242.0 | -30.4 | -28.7 |
EBIT margin | -194.9% | -210.3% | -134.9% | -15.5% | -21.5% |
Pre-tax income | -598.0 | -245.4 | -241.3 | -29.7 | -23.9 |
Income taxes | -49.1 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 8.2% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -549.0 | -245.4 | -241.3 | -32.7 | -26.8 |
Net margin | -233.9% | -115.6% | -134.6% | -16.7% | -20.1% |
|
Diluted EPS | ($1.63) | ($2.27) | ($47,035.67) | ($264,056.45) | ($26,823,000.00) |
Shares outstanding (diluted) | 337.8 | 108.1 | 0.0 | 0.0 | 0.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|